Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (251-260 of 496) with videos related to

Pageof 50
Sort By:
Journal of Medical Genetics|April 7, 2018
Current detection rates and time-to-detection of all identifiable <i>BRCA</i> carriers in the Greater London populationRanjit Manchanda, Oleg Blyuss, Faiza Gaba, et al.
International Journal of Cardiology|September 2, 2011
Determinants of urban-rural differences in cardiovascular risk factors in middle-aged women in India: a cross-sectional studyRavindra M Pandey, Rajeev Gupta, Anoop Misra, et al.
Genome Medicine|July 29, 2014
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survivalShahzia Anjum, Evangelia-Ourania Fourkala, Michal Zikan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General PopulationOleg Blyuss, Matthew Burnell, Andy Ryan, et al.
International Journal of Cancer|October 15, 2013
Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screeningJohannes W Pedersen, Aleksandra Gentry-Maharaj, Alexander Nøstdal, et al.
Health Technology Assessment (Winchester, England)|May 15, 2023
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Development of a multimarker assay for early detection of ovarian cancerZoya Yurkovetsky, Steven Skates, Aleksey Lomakin, et al.
Journal of Clinical and Translational Science|October 30, 2019
Measuring quality and outcomes of research collaborations: An integrative reviewBeth B Tigges, Doriane Miller, Katherine M Dudding, et al.
Journal of Clinical Epidemiology|November 16, 2010
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking studyNyaladzi Balogun, Aleksandra Gentry-Maharaj, Eva L Wozniak, et al.
Plos Computational Biology|August 29, 2024
Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detectionAlexander Ney, Nuno R Nené, Eva Sedlak, et al.
Pageof 50

Showing results (251-260 of 496) with videos related to

Sort By:
Pageof 50
Journal of Medical Genetics|April 7, 2018
Current detection rates and time-to-detection of all identifiable <i>BRCA</i> carriers in the Greater London populationRanjit Manchanda, Oleg Blyuss, Faiza Gaba, et al.
International Journal of Cardiology|September 2, 2011
Determinants of urban-rural differences in cardiovascular risk factors in middle-aged women in India: a cross-sectional studyRavindra M Pandey, Rajeev Gupta, Anoop Misra, et al.
Genome Medicine|July 29, 2014
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survivalShahzia Anjum, Evangelia-Ourania Fourkala, Michal Zikan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General PopulationOleg Blyuss, Matthew Burnell, Andy Ryan, et al.
International Journal of Cancer|October 15, 2013
Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screeningJohannes W Pedersen, Aleksandra Gentry-Maharaj, Alexander Nøstdal, et al.
Health Technology Assessment (Winchester, England)|May 15, 2023
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Development of a multimarker assay for early detection of ovarian cancerZoya Yurkovetsky, Steven Skates, Aleksey Lomakin, et al.
Journal of Clinical and Translational Science|October 30, 2019
Measuring quality and outcomes of research collaborations: An integrative reviewBeth B Tigges, Doriane Miller, Katherine M Dudding, et al.
Journal of Clinical Epidemiology|November 16, 2010
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking studyNyaladzi Balogun, Aleksandra Gentry-Maharaj, Eva L Wozniak, et al.
Plos Computational Biology|August 29, 2024
Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detectionAlexander Ney, Nuno R Nené, Eva Sedlak, et al.
Pageof 50